Gyre Therapeutics, Inc. (GYRE) Q3 2024 Earnings
GYRE·Reported November 13, 2024·Before market open
Gyre Therapeutics, Inc. reported Q3 2024 revenue of $25.5M. Diluted EPS came in at $0.02.
Revenue
$25.5M
Diluted EPS
$0.02
Financial Snapshot
Trailing eight quarters through Q3 2024
Q3 2024 Earnings FAQ
Common questions about Gyre Therapeutics, Inc.'s Q3 2024 earnings report.
Gyre Therapeutics, Inc. (GYRE) reported Q3 2024 earnings on November 13, 2024 before market open.
Gyre Therapeutics, Inc. reported revenue of $25.5M and diluted EPS of $0.02 for Q3 2024.
You can read the 10-Q periodic report (0000950170-24-126306) directly on SEC EDGAR. The filing index links above go to sec.gov.